Concordia Healthcare to buy assets of PE-backed Covis Pharma for $1.2 bln: Reuters
Canada's Concordia Healthcare Corp, which makes drugs for rare diseases and devices for diabetic patients, said it would buy some Swiss assets of Covis Pharma Holdings SARL for US$1.2 billion in cash, Reuters reported. Covis is controlled by affiliates of Cerberus Capital Management, Princeton Biopharma Capital Partners and Bourne Partners.
9 March 2015•1 min read
